Loading...
Loading...
By Sofía Garduño - Thu, 10/16/2025 - 10:28
This week, Mexico works to ensure medical continuity amid floods, boosts trade, and promotes workplace and women’s health initiatives.
https://mexicobusiness.news/tag/biosimilars
More Health
By Hector Salinas - Wed, 10/08/2025 - 07:00
As the global pharma market shifts due to the expansion of generics, Mexico is emerging as a leader in novel drug registration, writes Héctor Salinas.
By Juan Luis Serrano Leets - Tue, 09/23/2025 - 07:30
With the expiry of the July deadline for Mexico to implement USMCA's pharmaceutical provisions, Juan Luis Serrano Leets examines the landscape.
By Sofía Garduño - Wed, 07/23/2025 - 12:14
Molecular medicine offers superior cancer detection capabilities, which can improve treatment outcomes, says Grupo JUAMA’s Juan Pablo Vilar.
By Sofía Garduño - Mon, 05/05/2025 - 08:15
Healthcare has yet to face major disruption, but AI could be the catalyst for change, says Global Health Intelligence’s Guillaume Corpart.
By Juan Luis Serrano Leets - Mon, 03/10/2025 - 06:30
Mexico's patent and biosimilar regulations lack transparency and efficiency. Reform is needed, writes Juan Luis Serrano Leets.
By Sandra Sánchez-Oldenhage - Thu, 02/20/2025 - 08:30
Mexico can become a top pharma hub by boosting API production, nearshoring, and aligning trade policies, writes Sandra Sánchez-Oldenhage.
By Juan Luis Serrano Leets - Thu, 12/12/2024 - 16:00
With a newly designated head commissioner, Juan Luis Serrano looks at the key challenges COFEPRIS will likely face in 2025.
By Sofía Garduño - Tue, 07/09/2024 - 07:48
Continued efforts to enhance efficiency in regulatory processes foster a more conducive environment for innovation, says Sánchez Devanny.
By Sofía Garduño - Thu, 06/20/2024 - 10:11
Approximately 75% of Mexico's population relies on the public system to obtain medicines, leading to significant gaps, says Teva’s Rodrigo Fernández.
